Financhill
Buy
56

CSTM Quote, Financials, Valuation and Earnings

Last price:
$25.19
Seasonality move :
-1.32%
Day range:
$25.12 - $25.86
52-week range:
$7.33 - $27.25
Dividend yield:
0%
P/E ratio:
13.14x
P/S ratio:
0.43x
P/B ratio:
3.68x
Volume:
2.2M
Avg. volume:
1.9M
1-year change:
145.56%
Market cap:
$3.5B
Revenue:
$8.4B
EPS (TTM):
$1.94

Analysts' Opinion

  • Consensus Rating
    Constellium SE has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $28.88, Constellium SE has an estimated upside of 13.51% from its current price of $25.44.
  • Price Target Downside
    According to analysts, the lowest downside price target is $27.85 representing 100% downside risk from its current price of $25.44.

Fair Value

  • According to the consensus of 3 analysts, Constellium SE has 13.51% upside to fair value with a price target of $28.88 per share.

CSTM vs. S&P 500

  • Over the past 5 trading days, Constellium SE has overperformed the S&P 500 by 3.45% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Constellium SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Constellium SE has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Constellium SE reported revenues of $2.2B.

Earnings Growth

  • Constellium SE has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Constellium SE reported earnings per share of $0.80.
Enterprise value:
5.3B
EV / Invested capital:
1.83x
Price / LTM sales:
0.43x
EV / EBIT:
11.28x
EV / Revenue:
0.63x
PEG ratio (5yr expected):
0.03x
EV / Free cash flow:
32.62x
Price / Operating cash flow:
22.00x
Enterprise value / EBITDA:
6.65x
Gross Profit (TTM):
$857M
Return On Assets:
5.29%
Net Income Margin (TTM):
3.26%
Return On Equity:
33.33%
Return On Invested Capital:
9.52%
Operating Margin:
7.54%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $7.8B $7.3B $8.4B $1.7B $2.2B
Gross Profit $765.4M $635.5M $857M $131M $261M
Operating Income $393M $274.3M $474M $38M $166M
EBITDA $703.4M $588.2M $804M $115M $252M
Diluted EPS $0.86 $0.31 $1.94 -$0.33 $0.80
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $2.2B $2.2B $2B $1.8B $2.3B
Total Assets $5.3B $5.3B $4.9B $4.7B $5.4B
Current Liabilities $1.9B $1.8B $1.6B $1.4B $1.8B
Total Liabilities $4.9B $4.5B $4.2B $4B $4.4B
Total Equity $330.9M $802.6M $742M $727M $971M
Total Debt $2.1B $2B $2B $2B $1.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $429.7M $296.8M $504.3M -$9.7M $220.9M
Cash From Investing -$217.8M -$313.6M -$325.9M -$54.3M -$109.4M
Cash From Financing -$173.1M -$55.2M -$214.5M $46.9M -$114.1M
Free Cash Flow $65.6M -$110.4M $164M -$151.1M $111.7M
CSTM
Sector
Market Cap
$3.5B
$26.4M
Price % of 52-Week High
93.36%
72.39%
Dividend Yield
0%
0%
Shareholder Yield
5.31%
-3.25%
1-Year Price Total Return
145.56%
21.34%
Beta (5-Year)
1.508
0.598
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $24.66
200-day SMA
Buy
Level $16.13
Bollinger Bands (100)
Buy
Level 15.29 - 22.05
Chaikin Money Flow
Buy
Level 1.6M
20-day SMA
Buy
Level $23.98
Relative Strength Index (RSI14)
Buy
Level 64.43
ADX Line
Buy
Level 27.57
Williams %R
Neutral
Level -35.9127
50-day SMA
Buy
Level $21.48
MACD (12, 26)
Buy
Level 5.65
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level 7.7M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4358)
Sell
CA Score (Annual)
Level (-0.9241)
Buy
Beneish M-Score (Annual)
Level (-2.7562)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.9657)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Constellium SE is a holding company, which engages in the design and manufacture of rolled and extruded aluminum products. It operates through the following segments: Packaging and Automotive Rolled Products, Aerospace and Transportation, and Automotive Structures and Industry. The Packaging and Automotive Rolled Products segment includes the production in European and North American facilities. The Aerospace and Transportation segment involves the plate and sheet form, and limited volumes of extruded products. The Automotive Structures and Industry segment consists of extruded aluminum products and structural components, crash-management systems, body structures, side impact beams, and battery enclosures, fabricated hard and soft alloy extruded profiles. The company was founded on May 14, 2010 and is headquartered in Paris, France.

Stock Forecast FAQ

In the current month, CSTM has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CSTM average analyst price target in the past 3 months is $28.88.

  • Where Will Constellium SE Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Constellium SE share price will rise to $28.88 per share over the next 12 months.

  • What Do Analysts Say About Constellium SE?

    Analysts are divided on their view about Constellium SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Constellium SE is a Sell and believe this share price will drop from its current level to $27.85.

  • What Is Constellium SE's Price Target?

    The price target for Constellium SE over the next 1-year time period is forecast to be $28.88 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CSTM A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Constellium SE is a Buy. 3 of 3 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of CSTM?

    You can purchase shares of Constellium SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Constellium SE shares.

  • What Is The Constellium SE Share Price Today?

    Constellium SE was last trading at $25.19 per share. This represents the most recent stock quote for Constellium SE. Yesterday, Constellium SE closed at $25.44 per share.

  • How To Buy Constellium SE Stock Online?

    In order to purchase Constellium SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 9.59% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 4.77% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 2.09% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock